Every time an AI alert is sent,Jinling Pharmaceutical (SZ 000919, closing price: 8.03 yuan) released its annual performance report on the evening of March 29, saying that the operating income in 2021 will be about 2.809 billion yuan, a year-on-year increase of 12.18%; the net profit attributable to shareholders of the listed company is about 121 million yuan Yuan, an increase of 85.19% year-on-year; basic earnings per share was 0.2393 yuan, an increase of 85.22% year-on-year. It is proposed to distribute a cash dividend of 1 yuan (tax included) for every 10 shares, no bonus shares, and no conversion to increase.
The chairman of Jinling Pharmaceutical is Liang Yutang, male, 59 years old, with a bachelor’s degree; the president is Chen Yajun, male, 54 years old, with a bachelor’s degree.
1. In the past 30 days, no institution has conducted research on Jinling Pharmaceutical.
(Reporter Cai Ding)
Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. Do so at your own risk.
Copyright Notice
1This article is an original work of “Daily Economic News”.
2
Without the authorization of “Daily Economic News”, it may not be used in any way, including but not limited to reprinting, excerpting, copying or creating mirror images, etc. Violators will be held accountable.
3Copyright cooperation telephone: 021-60900099.